Minoxidil USP For Compounding (API)

Minoxidil USP For Compounding (API) is a pharmaceutical-grade active ingredient used in hair regrowth treatments, effectively addressing conditions such as androgenetic alopecia and female pattern hair loss. By enhancing blood flow to hair follicles and prolonging the anagen phase of hair growth, Minoxidil stimulates hair regrowth and helps reduce hair thinning. This compound enables healthcare providers to create customized topical solutions tailored to individual needs, optimizing results in hair restoration therapies. With its proven efficacy and adherence to strict quality standards, Minoxidil plays a vital role in dermatology and trichology, promoting scalp health and improving patient confidence.

Minoxidil USP active pharmaceutical ingredient (API) is a medication commonly used for the treatment of male and female pattern hair loss, also known as androgenetic alopecia. It works by widening blood vessels and increasing blood flow to the hair follicles, which promotes hair growth. Minoxidil USP is available in various forms, such as topical solution, foam, and oral tablets. The USP designation indicates that the ingredient complies with standards set by the United States Pharmacopeia and is of pharmaceutical grade quality. 

Minoxidil USP is a medication used for compounding in the treatment of hair loss. It is an over-the-counter topical solution that is applied to the scalp to stimulate hair growth and prevent further hair loss. This can be compounded into various forms such as creams, ointments, or gels, depending on the patient's individual needs. Minoxidil USP works by widening blood vessels and increasing blood flow to the hair follicles, which promotes hair growth and improves the delivery of essential nutrients to the scalp. It is typically used to treat male and female pattern baldness and may also be effective for other types of hair loss, such as alopecia areata.

CAS Number: 38304-91-5

Property: Light Sensitive